Insights On Clinical Technologies

  1. Automation Is Key For Companies Transitioning From R&D To Clinical Trials 11/14/2024

    Transitioning from R&D to clinical trials is challenging, but incorporating automation can be a big step toward overcoming technology challenges, streamlining operations, and reducing error rates.

  2. Patient Perspectives On eConsent 12/20/2023

    Explore how eConsent enables participants to engage meaningfully with consent documentation, addressing information dissemination, explanation, and recall challenges.

  3. The Scoop On The SCOPE Summit 2/19/2025

    From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.

  4. Using eConsent Data To Populate Site And Sponsor Data Systems 10/7/2024

    A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

  5. Measuring The True Patient Experience 5/15/2024

    Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

  6. Uncovering The Root Cause Of Clinical Trial Troubles 12/10/2024

    Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.

  7. Introducing A Smarter, More Cost-Effective Way To Run Clinical Trials 3/13/2025

    While early-phase trials often rely on less capable, cost-effective systems, the transition to more complex studies in later phases necessitates a more robust EDC system.

  8. The Promise And Peril Of AI In Clinical Trials 7/16/2024

    In clinical research, as with many industries, AI is met with both excitement and trepidation. The impact of AI and machine learning is starting to be felt across the pharmaceutical industry.

  9. Data Analytics' Role In Driving Commercialization And Clinical Success 11/15/2024

    Advanced analytics enable life sciences companies to optimize the trials, facilitating data-driven decisions that significantly reduce the time and financial burdens associated with drug development.

  10. Harnessing RWE For Effective External Control Arms In Clinical Trials 3/24/2025

    Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.